300765SZSE

2025 Annual Financial Report

CSPC Innovation Pharmaceutical Co., Ltd.·March 16, 2026·3 pages

✨ AI Summary

This report presents the audited financial statements of the company for the year ended December 31, 2025. Key figures show a revenue increase of 8.93% to RMB 2,157,680,212.70, while net profit attributable to shareholders decreased significantly by 548.80% to RMB -241,125,740.52. The company's total assets grew by 4.22%.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stone Pharmaceutical Co., Ltd.

2025 Annual Financial Report

Stone Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") financial statements, including the consolidated and parent company balance sheets as of December 31, 2025, the consolidated and parent company income statements for the year 2025, the consolidated and parent company cash flow statements, the consolidated and parent company statements of changes in owners' equity, and related financial statement notes have been audited by Deloitte Touche Tohmatsu Certified Public Accountants LLP, which issued an unqualified audit report with the standard no. P00247.

I. Major Financial Data and Indicators

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.